AVR vs GILD · rev $1.9M vs P/E 18, rev $7.80B
Anteris Technologies Global Corp. Common Stock (AVR) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Anteris Technologies Global Corp. Common Stock (AVR) is a medical instruments & supplies company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported AVR revenue for 2025-12-31 was $1.9M. Net income was -$94.1M. Revenue was down 29.2% from 2024-12-31 to 2025-12-31. AVR currently screens at market cap $287.2M.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
AVR currently screens at market cap $287.2M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the AVR and GILD stock pages for the full models.
Not investment advice.